Dolby Laboratories, Inc.
DLB
$67.48
$1.973.01%
NYSE
| 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | |
|---|---|---|---|---|---|
| Revenue | 307.02M | 315.55M | 369.56M | 357.00M | 304.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 307.02M | 315.55M | 369.56M | 357.00M | 304.81M |
| Cost of Revenue | 39.52M | 44.00M | 35.84M | 40.77M | 34.00M |
| Gross Profit | 267.51M | 271.54M | 333.72M | 316.23M | 270.81M |
| SG&A Expenses | 164.24M | 158.47M | 160.04M | 164.49M | 157.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 271.22M | 268.45M | 257.59M | 271.90M | 259.74M |
| Operating Income | 35.81M | 47.09M | 111.97M | 85.10M | 45.06M |
| Income Before Tax | 41.67M | 55.52M | 120.25M | 86.05M | 59.73M |
| Income Tax Expenses | -7.99M | 8.97M | 28.02M | 17.98M | 868.00K |
| Earnings from Continuing Operations | 49.65M | 46.54M | 92.23M | 68.07M | 58.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -322.00K | -471.00K | -433.00K | -248.00K | -296.00K |
| Net Income | 49.33M | 46.07M | 91.79M | 67.82M | 58.57M |
| EBIT | 35.81M | 47.09M | 111.97M | 85.10M | 45.06M |
| EBITDA | 57.80M | 69.02M | 133.51M | 107.46M | 66.42M |
| EPS Basic | 0.52 | 0.48 | 0.95 | 0.71 | 0.61 |
| Normalized Basic EPS | 0.31 | 0.35 | 0.80 | 0.59 | 0.38 |
| EPS Diluted | 0.51 | 0.48 | 0.94 | 0.70 | 0.60 |
| Normalized Diluted EPS | 0.31 | 0.35 | 0.79 | 0.58 | 0.37 |
| Average Basic Shares Outstanding | 95.63M | 95.90M | 96.33M | 95.62M | 95.40M |
| Average Diluted Shares Outstanding | 96.85M | 96.90M | 97.47M | 97.15M | 96.59M |
| Dividend Per Share | 0.36 | 0.33 | 0.33 | 0.33 | 0.33 |
| Payout Ratio | 64.03% | 68.66% | 34.67% | 46.52% | 48.84% |